Fig. 5

Correlation between H2BC9 and drug sensitivity in HNSCC. a–t Drug sensitivity of patients with HNSCC with high- vs. low- H2BC9 expression. a–t were analyzed using the Wilcoxon rank sum test. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, HNSCC: head and neck squamous cell carcinoma